Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


Articles published in Int J Radiat Oncol Biol Phys

Retrieve available abstracts of 267 articles:
HTML format
Text format



Single Articles


    March 2017
  1. FOGH SE, Deshmukh S, Berk LB, Dueck AC, et al
    A Randomized Phase 2 Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy-Induced Esophagitis During the Treatment of Lung Cancer: Results of NRG Oncology RTOG 1012.
    Int J Radiat Oncol Biol Phys. 2017;97:786-796.
    PubMed     Text format     Abstract available


  2. VERMA V, Shostrom VK, Zhen W, Zhang M, et al
    Influence of Fractionation Scheme and Tumor Location on Toxicities After Stereotactic Body Radiation Therapy for Large (>/=5 cm) Non-Small Cell Lung Cancer: A Multi-institutional Analysis.
    Int J Radiat Oncol Biol Phys. 2017;97:778-785.
    PubMed     Text format     Abstract available


    February 2017
  3. OHRI N, Bodner WR, Halmos B, Cheng H, et al
    18F-Fluorodeoxyglucose/Positron Emission Tomography Predicts Patterns of Failure After Definitive Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017;97:372-380.
    PubMed     Text format     Abstract available


    January 2017
  4. GIULIANI M, Hope A, Guckenberger M, Mantel F, et al
    Stereotactic Body Radiation Therapy in Octo- and Nonagenarians for the Treatment of Early-Stage Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017 Jan 9. pii: S0360-3016(17)30023.
    PubMed     Text format     Abstract available



  5. Erratum to Guo W, Du S, Yang L, et al. Stat3 activation mediates stem cell, DNA repair, and immunosuppressive properties in crizotinib-resistance EML4-ALK-rearranged lung cancer. Int J Radiat Oncol Biol Phys 2016;96:S76-S77.
    Int J Radiat Oncol Biol Phys. 2017;97:210.
    PubMed     Text format    


  6. HIGGINS KA, O'Connell K, Liu Y, Gillespie TW, et al
    National Cancer Database Analysis of Proton Versus Photon Radiation Therapy in Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017;97:128-137.
    PubMed     Text format     Abstract available


    December 2016
  7. BROOKS ED, Sun B, Zhao L, Komaki R, et al
    Stereotactic Ablative Radiation Therapy is Highly Safe and Effective for Elderly Patients With Early-stage Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016 Dec 21. pii: S0360-3016(16)33596.
    PubMed     Text format     Abstract available


  8. VIDETIC GM
    Early-Stage Lung Cancer, Surgery, and Stereotactic Body Radiation Therapy: Quality of Life.
    Int J Radiat Oncol Biol Phys. 2016;96:927-930.
    PubMed     Text format    


  9. IRIE D, Saitoh JI, Shirai K, Abe T, et al
    Verification of Dose Distribution in Carbon Ion Radiation Therapy for Stage I Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96:1117-1123.
    PubMed     Text format     Abstract available


  10. STAHL JM, Ross R, Harder EM, Mancini BR, et al
    The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96:1011-1020.
    PubMed     Text format     Abstract available


    November 2016
  11. BRADLEY J, Hu C
    Learning From Trials on Radiation Dose in Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96:748-750.
    PubMed     Text format     Abstract available


  12. RAMROTH J, Cutter DJ, Darby SC, Higgins GS, et al
    Dose and Fractionation in Radiation Therapy of Curative Intent for Non-Small Cell Lung Cancer: Meta-Analysis of Randomized Trials.
    Int J Radiat Oncol Biol Phys. 2016;96:736-747.
    PubMed     Text format     Abstract available


  13. VERMA V, Simone CB 2nd, Allen PK, Gajjar SR, et al
    Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016 Nov 2. pii: S0360-3016(16)33392.
    PubMed     Text format     Abstract available


  14. INOUE T, Widder J, van Dijk LV, Takegawa H, et al
    Limited Impact of Setup and Range Uncertainties, Breathing Motion, and Interplay Effects in Robustly Optimized Intensity Modulated Proton Therapy for Stage III Non-small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96:661-9.
    PubMed     Text format     Abstract available


  15. DU S, Lockamy V, Zhou L, Xue C, et al
    Stereotactic Body Radiation Therapy Delivery in a Genetically Engineered Mouse Model of Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96:529-37.
    PubMed     Text format     Abstract available


    October 2016
  16. BOYER MJ, Williams C, Kelley MJ, Salama JK, et al
    Survival With Stereotactic Body Radiation Therapy (SBRT) and Conventional Radiation Therapy (CRT) in Stage I Non-Small Cell Lung Cancer Patients in the Veterans Affairs System.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  17. VIDETIC GM, Gomez Suescun JA, Stephans KL, Bogart JA, et al
    A Phase 2 Randomized Study of 2 Stereotactic Body Radiation Therapy (SBRT) Regimens for Medically Inoperable Patients With Node-Negative, Peripheral Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  18. BEZJAK A, Paulus R, Gaspar LE, Timmerman RD, et al
    Efficacy and Toxicity Analysis of NRG Oncology/RTOG 0813 Trial of Stereotactic Body Radiation Therapy (SBRT) for Centrally Located Non-Small Cell Lung Cancer (NSCLC).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  19. QIU M, Wu Z, Yuan Z, Meng M, et al
    MIR384, Inhibited By NF-Kb, Enhances Radiosensitivity in Human Non-Small Cell Lung Cancer Via Modulating DNA Damage Response and Repair Signaling.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  20. GUO W, Du S, Yang L, Dicker AP, et al
    Stat3 Activation Mediates Stem Cell, DNA Repair, and Immunosuppressive Properties in Crizotinib-Resistance ELM4-ALK-Rearranged Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  21. LOK BH, Feng Y, Gardner EE, Yu GK, et al
    SLFN11 Is Necessary for Single Agent Sensitivity to Talazoparib, a Potent PARP Inhibitor, But Not for Radiosensitization in Small Cell Lung Cancer (SCLC) Cell Lines and Patient-Derived Xenografts (PDX).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  22. FENG W, Fu XL, Cai XW, Zhang Q, et al
    The Differential Impact of Postoperative Radiation Therapy for Completely Resected Stage IIIA (N2) Non-Small Cell Lung Cancer: Based on the Risk Prediction Model for Locoregional Recurrence.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  23. HERSKOVIC A, Christos P, Mauer E, Nagar H, et al
    The Role of Postoperative Radiation Therapy in pN2 Non-Small Cell Lung Cancer: An Analysis of the National Cancer Data Base.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  24. GAO S, Corso CD, Detterbeck FC, Boffa D, et al
    Effects of Adjuvant Therapy on Survival in T3N0 Non-Small Cell Lung Cancer Invading the Chest Wall.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  25. DALWADI SM, Szeja S, Teh BS, Butler EB, et al
    Outcomes in Elderly Stage I Non-Small Cell Lung Cancer in the Stereotactic Body Radiation Therapy Era: A Surveillance, Epidemiology, and End Results Analysis.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  26. MAGNUSON WJ, Amini A, Patil T, Kavanagh BD, et al
    Deferring Radiation Therapy for Brain Metastases in Patients With EGFR-Mutant Non-Small Cell Lung Cancer: A Multi-Institutional Analysis.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  27. REDMOND KJ, Hales RK, Zhou XC, Kummerlowe M, et al
    A Prospective Study of Hippocampal-Sparing Prophylactic Cranial Irradiation (PCI) in Limited-Stage Small Cell Lung Cancer (SCLC).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  28. MATTONEN SA, Palma DA, Johnson C, Louie AV, et al
    Detection of Local Cancer Recurrence After Stereotactic Ablative Radiation Therapy (SABR) for Lung Cancer: Physician Performance Versus Radiomic Assessment.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  29. MCWILLIAM A, Faivre-Finn C, Kennedy J, Kershaw L, et al
    Data Mining Identifies the Base of the Heart as a Dose-Sensitive Region Affecting Survival in Lung Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  30. JACKSON MW, Schubert LK, Jones B, Castillo R, et al
    A Novel Lung Function Imaging Modality for Surgical Lung Cancer Evaluation.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  31. TANG C, Amer A, Hobbs B, Li X, et al
    Pathology-Based Non-Small Cell Lung Cancer Radiomics Signature Describing the Local Tumor Immune Environment: Discovery and Validation.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  32. CHAUDHURI AA, Lovejoy AF, Chabon JJ, Newman A, et al
    CAPP-Seq Circulating Tumor DNA Analysis for Early Detection of Tumor Progression After Definitive Radiation Therapy for Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  33. HOLMES JA, Chen RC
    Racial Disparities in Time From Diagnosis to Treatment for Stage IA Non-Small Cell Lung Cancer (NSCLC).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  34. MANNING M, Cykert S, Eng E, Yee MK, et al
    Reducing Racial Disparities in Treatment for Early-Stage Lung Cancer With a Multimodal Intervention.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  35. SAPIR E, Tao Y, Lin J, Kollar L, et al
    Surgical Resection or Stereotactic Body Radiation Therapy for Sarcoma Patients With Pulmonary Metastases.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  36. ALLEN BG, Schoenfeld JD, Sibenaller ZA, Mapuskar KA, et al
    Pharmacological Ascorbate Enhances the Response of Non-Small Cell Lung Cancer (NSCLC) to Radiation and Chemotherapy Via Disruptions of Redox Active Iron Leading to Increased H2O2.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  37. YAMAMOTO T, Kabus S, Bal M, Keall P, et al
    Computed Tomography Ventilation Image Guided Adaptive Functional Avoidance in Radiation Therapy for Locally Advanced Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  38. KANG M, Huang S, Solberg TD, Mayer R, et al
    A Study of the Beam-Specific Interplay Effect in Proton Pencil Beam Scanning Delivery in Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  39. DHOU S, Ionascu D, Cai W, Hurwitz M, et al
    Interfraction Variability of Motion Models Derived Using Patient 4-Dimensional Cone Beam Computed Tomography Images for Lung Cancer Stereotactic Body Radiation Therapy (SBRT) Patients.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  40. AKTHAR AS, Koshy M, Ferguson MK, Murgu S, et al
    Does Endoscopic Bronchial Ultrasound (EBUS) Impact Outcomes in Stage I Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Hypofractionated Radiation Therapy (HFRT)?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  41. AHMED KA, Creelan BC, Kim S, Dilling TJ, et al
    Safety and Tolerability of Extracranial Radiation Therapy and Immune Checkpoint Inhibitors Among Patients With Metastatic Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  42. GRENDAROVA P, Arora R, Bebb GD, D'Silva A, et al
    Sarcopenia Is Associated With Worse Overall Survival in Patients With Locally Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  43. ZAKI M, Xu Y, Dominello MM, Dyson G, et al
    Radiation Dose to the Heart and Mortality in Patients Receiving Definitive Chemoradiation Therapy for Stage III Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  44. PALY J, Shaikh T, Scott WJ, Flieder D, et al
    Comparative Effectiveness of Standard Versus High-Dose Neoadjuvant Chemoradiation Followed by Surgery for Locally Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  45. LAN M, Xu T, Yue J, Yang J, et al
    Polymorphisms of BMP4 and HIF-1A Are Associated With Patient-Reported Symptoms in Non-Small-Cell Lung Cancer Patients Treated With Definitive Chemoradiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  46. VOGEL J, Wang X, Troxel A, Simone CB 2nd, et al
    Prospective Assessment of Demographic Characteristics Associated With Worse Health-Related Quality of Life Measures Following Definitive Chemoradiation in Patients With Locally Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  47. BROWER JV, Amini A, Hullett CR, Wojcieszynski AP, et al
    Dose-Escalated Radiation Therapy Is Associated With Improved Survival in Patients With Stage III Non-Small Cell Lung Cancer: Analysis of the National Cancer Data Base.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  48. KIM H, Ahn YC, Pyo HR, Oh D, et al
    Are New ypN Stages Predictive of Survival in 477 Lung Cancer Patients Who Underwent Trimodality Therapy for Initial pN2 Disease?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  49. ZHANG H, Yan L, Huang K, Campbell J, et al
    Normalized Median Geodesic Distance, a Novel Shape Descriptor, Predicts Survival in Non-Small Cell Lung Cancer After Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  50. VAN TIMMEREN JE, Leijenaar RT, van Elmpt W, Lambin P, et al
    Interchangeability of a Radiomic Signature Between Conventional and Weekly Cone Beam Computed Tomography Allowing Response Prediction in Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  51. PAUL J, Gore EM, Li A
    Quantitative Computed Tomography for Tumor Response Assessment During Radiation Therapy for Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  52. DE JONG E, van Elmpt W, Leijenaar RT, Carvalho S, et al
    Prospective Validation of a Prognostic Computed Tomography-Based Radiomic Signature in Stage IV Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  53. DING X, Qian D, Cheng J, Yuan Z, et al
    In Vitro and In Vivo Radiosensitization by Telomerase Inhibitor BRBR1532 in Human Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  54. LOCKNEY NA, Pei X, Blumberg LE, Chan TA, et al
    PIK3CA Activating Mutations Are Associated With Decreased Local Control in Lung Cancer Brain Metastases Treated With Radiation.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  55. HOLMES JA, Chen RC
    Adoption of Stereotactic Body Radiation Therapy (SBRT) for Stage IA Non-Small Cell Lung Cancer (NSCLC) Across the United States and Patterns of Dose Prescriptions.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  56. STAHL JM, Ross R, Harder EM, Mancini BR, et al
    A Biologically Effective Dose of >/=105 Gy Is Associated With Improved Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  57. JAIN S, Amini A, Rusthoven CG
    High-Dose Thoracic Radiation Therapy Is Associated With Improved Survival in Metastatic Non-Small Cell Lung Cancer (NSCLC).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  58. VALDES G, Berman AT, Hann-Hsiang C, Solberg TD, et al
    Machine Learning Analysis Can Identify Clinical and Dosimetric Factors Predictive of Chest Wall Syndrome in Patients With Stage I Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  59. CHAO HH, Berman AT, Mick R, Ciunci C, et al
    Central Volume Target Overlap and Esophageal Dose Predict for Toxicity in a Prospective Study of Reirradiation for Non-Small Cell Lung Carcinoma Using Proton Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  60. LAMMERS A, Golden S, Thomas CR Jr, Mitin T, et al
    Lung Cancer Specialists' Opinions on Treatments for Stage I Lung Cancer: A Multidisciplinary Survey.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  61. CHEN B, Zhou L, He J, Xiong W, et al
    Neurocognitive Function and Quality of Life in EGFR-Mutated Non-Small Cell Lung Cancer Patients With Brain Metastases Treated With Icotinib and Whole-Brain Radiation: Results of a Phase 1 Trial.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  62. OFORI M, Sekhar K, Crooks P, Penthala N, et al
    Targeting NPM1 for the Radiosensitization of Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  63. MAK RH, Hermann G, Aerts H, Chen AB, et al
    Outcomes by EGFR, KRAS and ALK Genotype After Combined Modality Therapy for Locally Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  64. YANG J, Xu T, Yuan X, Gomez DR, et al
    Single Nucleotide Polymorphisms in BMP/Smad4/Hamp Are Associated With Outcome of Patients Receiving Definitive Radiation Therapy for Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  65. WALIANY S, Shultz DB, Gensheimer MF, Loo BW Jr, et al
    Role of Surveillance Imaging Versus Symptoms and Signs in Detection of Recurrence of Non-Small Cell Lung Cancer After Curative Intent Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  66. KUMAR S, Li X, Feddock J, McGarry RC, et al
    An Update on Results Regarding a Prospective Study of SBRT for Post-chemoradiation Residual Disease in Stage II/III Non-small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  67. ZHANG Q, Fu X
    Safety of Dose Escalation by Simultaneous Integrated Boosting Radiation Dose in Unresectable Stage III Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  68. LIANG J
    Combination Therapy With Celecoxib and Concurrent Chemoradiation Therapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer: Primary Analysis of a Randomized Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  69. SLOTMAN BJ, Faivre-Finn C, van Tinteren H, Keijser A, et al
    Identifying Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Most Likely to Benefit From Intensive Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  70. SENTER J, Hooker C, Lang M, Voong KR, et al
    Thoracic Multidisciplinary Clinic Improves Survival in Patients With Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  71. LI Y, Liang S, Zhou Z, Cai Y, et al
    Risk Factor Study of Radiation Pneumonitis Focused on Subclinical Interstitial Lung Disease in Definitive Radiation Therapy for Non-Small Cell Lung Cancer: A Single-Institution Experience.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  72. DENG L, Zhang J, Liu Y, Sun X, et al
    Failure Pattern of Oligometastatic EGFR-Mutant Non-Small Cell Lung Cancer Treated With Tyrosine Kinase Inhibitors: Implication of Upfront Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  73. TSUJINO K, Kubota H, Kawaguchi H, Matsumoto Y, et al
    Risk Factors Associated With Fatal Radiation Pneumonitis after Concurrent Chemoradiation Therapy for Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  74. WANG K, Eblan MJ, Zagar TM, Lee CB, et al
    Cardiac Toxicity After Radiation for Stage III Non-Small Cell Lung Cancer: Pooled Analysis of Several Prospective Dose-Escalation Trials Delivering 70 to 90 Gy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  75. BARNEY C, Scoville N, Haglund KE, Grecula JC, et al
    Radiation Dose to the Thoracic Vertebral Bodies Is Associated With Acute Hematologic Toxicity in Patients Receiving Concurrent Chemoradiation for Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  76. GORE EM, Hu C, Ad VB, Robinson CG, et al
    Impact of Incidental Cardiac Radiation on Cardiopulmonary Toxicity and Survival for Locally Advanced Non-Small Cell Lung Cancer: Reanalysis of NRG Oncology/RTOG 0617 With Centrally Contoured Cardiac Structures.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  77. BISSONNETTE JP, Bezjak A, Becker N, Vines D, et al
    Serial 4-Dimensional (4D) Computed Tomography/4D Positron Emission Tomography Imaging to Predict and Monitor Response for Locally Advanced Non-Small Cell Lung Cancer Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  78. POKHREL D, Sood SS, Shen X, McClinton CM, et al
    Modeling of Tumor Control Probability and Rib Toxicity for Peripherally Located Non-Small Cell Lung Cancer (NSCLC) Lesions Treated With Monte Carlo-Based Dose Algorithm.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  79. KIMURA T, Nakashima T, Saito A, Takeuchi Y, et al
    Combined Ventilation and Perfusion Imaging Correlates With the Dosimetric Parameters of Radiation Pneumonitis in Radiation Therapy Planning for Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  80. GAO S, Kim AW, Detterbeck FC, Boffa D, et al
    Indications for Invasive Mediastinal Staging in Patients With Early Non-Small Cell Lung Cancer Staged With Positron Emission Tomography/Computed Tomography.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  81. WU J, Gensheimer MF, Dong X, Rubin DL, et al
    Intratumor Partitioning of Serial Computed Tomography and FDG Positron Emission Tomography Images Identifies High-Risk Tumor Subregions and Predicts Patterns of Failure in Non-Small Cell Lung Cancer After Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  82. SHIOYAMA Y, Yamamoto N, Saitoh JI, Fujii O, et al
    Multi-institutional Retrospective Study of Carbon Ion Radiation Therapy for Stage I Non-Small Cell Lung Cancer: Japan Carbon Ion Radiation Oncology Study Group.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  83. LOUIE AV, Chen H, Van Werkhoven E, Smit E, et al
    Quality of Life Following Stereotactic Ablative Radiation Therapy Versus Surgery for Early-Stage Lung Cancer: Results From the ROSEL Randomized Controlled Trial and a Systematic Review.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  84. OLSON AC, Patel K, Mowery YM, Wynne J, et al
    Anti-PD-1 Therapy and Stereotactic Radiation for Melanoma and Non-Small Cell Lung Cancer Patients with Brain Metastases: A 2-Institution Series.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  85. CHUNG SY, Chang JH, Lee CG, Suh CO, et al
    Optimal Dose and Volume for Postoperative Radiation Therapy in Patients With 1 to 4 Brain Metastases From Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  86. MUCCIGROSSO DJ, Maughan NM, Wan H, Lu Y, et al
    The Relationship Between Implantation Distance and Fraction Number With Fiducial Accuracy During Lung Cancer Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  87. O'CONNELL D, Shaverdian N, Kishan AU, Thomas DH, et al
    Clinical Validation and Implementation of the 5DCT Technique for Breathing-Gated Image Generation for Lung Cancer Treatment Planning.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  88. ZHOU M, Zou L, Chen QQ, Tian Y, et al
    The Assessment of Cognitive Function in Lung Cancer Patients With Brain Metastases Before and After Whole-Brain Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  89. ZHANG H, Jin JY, Wang W, Campbell J, et al
    A Prognostic Model Combining Genetic Variations in the Transforming Growth Factor-Beta1 Pathway and Clinical Factors for Non-Small Cell Lung Cancer After Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  90. KATZ LM, Shin S, McCarthy A, Schiff PB, et al
    The Use of Stereotactic Body Radiation Therapy Treatment for Lung Cancer in the Primary and Salvage Settings: Defining a New Clinical Niche.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  91. LIU M, Ge C, Liu B, Zhang Y, et al
    A Dosimetric Comparative Study of Rapid-ARC and Rapid-ARCFFF for Primary Lung Cancer or Lung Metastases With Hypofractionated Radiation Therapy of Small Target Volume.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  92. MA CM, Eldib A, Chibani O, Mora G, et al
    Exploring the Dosimetric Advantages of Cobalt Beams for Lung Cancer Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  93. KU E, Desai AY, Fang D, Lawrence C, et al
    Toxicity Profile in Non-Small Cell Lung Cancer Patients Treated With Lung Stereotactic Body Radiation Therapy Using the Modified Dynamic Conformal Arc (MDCA) Technique.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  94. SAKATA Y, Hirai R, Taguchi Y, Mori S, et al
    Marker-less Tumor Tracking for Lung Cancer by Tumor Image Pattern Learning.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  95. IMANO N, Nishibuchi I, Kimura T, Nakashima T, et al
    Impact of Expiratory Tumor Motion Patterns on Dose-Volume Histogram in Treatment Phase Selection of Respiratory Gating Radiation Therapy for Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  96. CHALUBINSKA-FENDLER J, Karolczak L, Fendler W, Bury J, et al
    Feasibility of Texture Analysis-Based Dosimetry in Computed Tomography Scans During Radiation Therapy of Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  97. IRAMINA H, Nakamura M, Iizuka Y, Mitsuyoshi T, et al
    Accuracy of Target Motion Trajectory in 4-Dimensional Cone Beam Computed Tomography for Lung Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  98. HASHIMOTO M, Ito Y, Takahashi R, Nakajima M, et al
    Four-Dimensional Dose Reconstruction for Lung Cancer in Volumetric Modulated Arc Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  99. GRINCHAK TA, Sokolovic C, Holland B, Parent T, et al
    Response Criteria in Solid Tumors (PERCIST/RECIST) and SUVmax in Early-Stage Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  100. DIAMANT AA, Seuntjens J, El Naqa I, Al-Halabi H, et al
    Prediction of Distant Metastasis Using Dose-Volume Metrics in Non-Small Cell Lung Cancer Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  101. MAHMOOD J, Murti SC, Zaveri SR, Shukla HD, et al
    Caveolin-1: A Novel Prognostic Biomarker for Radioresistance in Non-Small Cell Lung Carcinoma (NSCLC) and Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  102. COROLLER TP, Agrawal V, Narayan V, Grossmann P, et al
    Radiomics Predict Pathological Response in Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  103. HUYNH E, Coroller TP, Narayan V, Agrawal V, et al
    Radiomics Analysis of Stereotactic Body Radiation Therapy Patients With Lung Cancer Predicts Recurrent Disease.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  104. QIAN D, Cheng J, Ding X, Yuan Z, et al
    Phosphoglycerate Mutase 5-Mediated Mitochondrial Apoptosis/Necrosis Pathways and Mitophagy Determine the Mode of Cell Death Induced by Ionizing Radiation in Non-Small-Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  105. YANG D, O'Leary C, Deraska PV, D'Andrea AD, et al
    Exploiting Homologous Recombination Defects in N on-Small Cell Lung Cancer Through Combined PARP and Wee1 Inhibition.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  106. ZHANG H, Wan C, Yang C, Qin Y, et al
    Stereotactic Body Radiation Therapy Gains Radiobiological Advantages Not in Non-Small Cell Lung Cancer Cells After Radiation But in Early Passage Cells Compared to Conventional Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  107. TAI A, Liu F, Li A
    Modeling Tumor Regrowth After Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  108. KARANAM NK, Srinivasan K, Sishc B, Ding LH, et al
    Tumor Treatment Fields Can Enhance the Radio- and Chemosensitivity of Non-Small Cell Lung Cancer Cell Lines.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  109. SERRANO N, Alam A, Rabender C, Weiss E, et al
    Analysis of Circulating Tumor Exosomes: Their Role in the Tissue Microenvironment and Ability to Serve as a Biomarker for Recurrence in Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  110. MUNSHI A, Griffith J, Jin H, Algan O, et al
    Biological Effects of Proton and Photon Radiation in Non-Small Cell Lung Cancer Cell Lines.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  111. PATEL C, Attia A, Shinohara ET, Perkins SM, et al
    Post-treatment Cardiac Mortality in Non-Small Cell Lung Cancer Patients in the Modern Era.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  112. PATEL C, Attia A, Shinohara ET, Perkins SM, et al
    Immediate 90-Day Stress-Related Cardiovascular Mortality: The Shock of Lung Cancer Diagnosis.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  113. YANG K, Miller JA, Balagamwala EH, Angelov L, et al
    Spine Stereotactic Body Radiation Therapy for Palliative Management of Metastatic Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  114. GIAP F, Lau SK, Gannavaparu BS, Iyengar P, et al
    Impact of Baseline Cachexia in Non-Small Cell Lung Cancer on Radiation Therapy Utilization and Survival.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  115. CHOONG ES, Yang J, Kennedy C, Tse RV, et al
    Pathological Stage IIIA, pN2 Non-Small Cell Lung Cancer (NSCLC) With Staging 18-FDG Positron Emission Tomography (PET): Is There a Role for Adjuvant Radiation Therapy (ART)?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  116. KONG FM, Campbell J, Jin JY, Jolly S, et al
    Risk Factors for Noncancer Progression-Associated Death in Patients With Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  117. KANG KH, Sharma N, Effird JT, Yang M, et al
    Pretreatment Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios and Lymphocyte Nadir as Predictors for Outcome in Stage III Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  118. ANDERSON E, Filippi AR, Badellino S, Ricardi U, et al
    Imaging Features Associated With Disease Progression After Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Multi-Institutional Pooled Analysis.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  119. DAJAC J, Bhattal G, Keller A, Pavlovic Z, et al
    Evaluation of Overall Survival Following Stereotactic Radiosurgery (SRS) for Non-Small Cell Lung Cancer Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  120. SOIKE M, Farris M, Russell G, Feehs K, et al
    Are Individual Chemotherapy Agents Given with Radiation Related to Improved Outcomes in Patients with Stage IIB-IIIB Non-Small Cell Lung Cancer?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  121. WILD AT, Jackson A, Kohutek ZA, Wu AJ, et al
    Planning Target Volume and FDG-PET Maximum Standardized Uptake Value, But Not Dosimetric Parameters of Target Coverage, Predict for Local Recurrence After Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  122. TJONG MC, Faruqi S, Helou J, Zhang L, et al
    Post-Stereotactic Body Radiation Therapy (SBRT) Tumor Response and Inflammatory Changes as Predictors of Nonlocal Failure and Survival Outcomes in Patients With Stage I Non-Small Cell Lung Cancer (NSCLC).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  123. LEE A, Ohri N, Purswani J, Yaparpalvi R, et al
    Local Control After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Tale of 2 Schedules?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  124. HARRIS DM, Popple RA, Jackson BF, Singh KP, et al
    Analysis of Predictive Factors for Pneumonitis in Lung Cancer Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  125. JOSEPH N, McWilliam A, Kennedy J, Faivre-Finn C, et al
    A Higher Integral Heart Dose Is Associated With Lymphocytopenia in Non-Small Cell Lung Cancer Patients Treated With Intensity Modulated Radiation Therapy and Concurrent Chemotherapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  126. FEEHS K, Soike M, Russell G, Farris M, et al
    Difference in Demographics for Patients With Stage IIB-IIIB Non-Small Cell Lung Cancer Receiving Combined Modality Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  127. ADIL K, Boustead A, El Naqa I, Seuntjens J, et al
    Stereotactic Body Radiation Therapy With 48 Gy in 3 Fractions Is an Effective Treatment for Early-Stage Non-Small Cell Lung Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  128. RICE SR, Molitoris JK, Vyfhuis M, Mohindra P, et al
    Magnetic Resonance Imaging Brain Staging in Stage I-III Non-Small Cell Lung Cancer (NSCLC): Incidence and Clinicopathologic Factors in Asymptomatic Brain Metastases at Diagnosis.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  129. BAZAN JG, Barney C, Scoville N, Haglund KE, et al
    Increased Posttreatment Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Marker for Worse Overall Survival in Patients Receiving Concurrent Chemoradiation for Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  130. JOLLY S, Sun Y, Bi N, Tewari M, et al
    Using a Pretreatment Serum microRNA Signature to Identify Non-Small Cell Lung Cancer Patients Who Benefit From Radiation Dose Escalation.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  131. BLEDSOE TJ, Rutter CE, Lester-Coll NH, Bi X, et al
    Radiation to Oligoprogessive Sites of Disease Can Prolong the Duration of Response to Immune Checkpoint Inhibitors in Patients With Metastatic Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  132. JOO JH, Song SY, Park J, Choi EK, et al
    Lymphocyte Depletion by Radiation Therapy Alone Is Associated With Poor Survival in Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  133. YOON S, Shaikh T, Ross EA, Bauman J, et al
    Patterns and Predictors of Failure Following Definitive Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer (NSCLC).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  134. KING M, Kong FM, Campbell J, Goetz R, et al
    Cytokine Signature During Early Treatment May Predict Midtreatment Positron Emission Tomography/Computed Tomography and Survival in Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  135. SURI JS, Bergsma DP, Moravan MJ, Usuki KY, et al
    Clinical Presentation and Distribution of Solitary Brain Metastases Among Non-Small Cell Lung Cancer (NSCLC) Patients in the Modern Staging Era.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  136. MA SJ, Gomez Suescun J, Wang K, Singh AK, et al
    Thoracic Radiation Therapy in Extensive-Stage Small Cell Lung Cancer: A Single-Institution Experience.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  137. HERSKOVIC A, Chitti BS, Christos P, Wernicke AG, et al
    Addition of Surgery After Radiation Significantly Improves Survival in Stage IIIB Non-Small Cell Lung Cancer: A Population-Based Analysis.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  138. ERGEN SA, Dincbas FO, Yucel B, Akyurek S, et al
    Risk Factors of Radiation Pneumonitis in the Patients With Non-Small Cell Lung Cancer Treated by Concomitant Chemoradiation Therapy: TOG/TROD Lung Cancer Study Group.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  139. ZHANG Y, Zanos P, Jackson I, Zhang X, et al
    Psychological Stress Enhances Tumor Growth and Diminishes Radiation Response in Preclinical Model of Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  140. HOBSON S, Abugharib A, Schipper M, Matuszak MM, et al
    Predictors of Acute Esophagitis in Lung Cancer Patients Treated With Definitive Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  141. XU T, Fan J, Levy LB, Zhuang Y, et al
    Predictive Value of Serum Hepcidin for Disease Outcome in Non-Small Cell Lung Cancer Patients Received Definitive Radio(chemo)therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  142. PALMA DA, Kwan K, Gaede S, Landis M, et al
    A Phase II Trial Measuring the Integration of Stereotactic Ablative Radiation Therapy (SABR) Plus Surgery for Early-Stage Non-Small Cell Lung Cancer (MISSILE-NSCLC): Interim Safety Results.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  143. JULOORI A, Vassil AD, Woody NM, Stephans KL, et al
    Managing Local Recurrence After Primary Resection of Non-Small Cell Lung Cancer: The Role for Salvage Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  144. VYFHUIS M, Bhooshan N, Feliciano J, Burrows W, et al
    Implications of Pathological Complete Response (pCR) at the Primary Tumor After Chemoradiation Therapy (CRT) Followed by Surgical Resection in Patients With Locally Advanced, Non-Small Cell Lung Cancer (LANSCLC).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  145. CHITTI BS, Wernicke AG, Parashar B
    Radiation Therapy Improves Survival in Elderly Patients With Locally Advanced Non-Small Cell Lung Cancer: A Population-Based Analysis.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  146. SHEN S, Spencer SA, Singh SP
    Application of 4-Dimensional ECG-gated Computed Tomography for Planning Tumors Adjacent to the Heart for Radiation Therapy of Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  147. GAO S, Corso CD, Wang EH, Blasberg J, et al
    Timing of Surgery After Neoadjuvant Chemoradiation in Clinical Stage IIIA Non-Small Cell Lung Cancer With Mediastinal Nodal Involvement.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  148. FERRAZZA P, Menichelli C, Fanelli A, Grespi S, et al
    Thoracic Reirradiation After Previous Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer and Lung Metastases: The Role of Ablative Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  149. SMITH AW, Chitti BS, Wernicke AG, Parashar B, et al
    Increasing Use of Combination Surgery and Radiation Compared to Surgery or Radiation Alone Has Improved Survival in Patients With Stage IIIA Non-Small Cell Lung Cancer: A Population-Based Study of Patterns of Care.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  150. WALKER AL, Marwaha G, Bonomi P, Sher DJ, et al
    Toxicity and Efficacy of Thoracic Reirradiation With Split-Course Chemoradiation Therapy for the Curative Treatment of Recurrent Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  151. HIGGINS KA, Jia Y, Liu Y, Force S, et al
    Lung Stereotactic Body Radiation Therapy (SBRT) Versus Pneumonectomy in Patients With Non-Small Cell Lung Cancer (NSCLC) Ages 70 or Older.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  152. AKYUREK S, Ozdemir BS, Sert F, Yalman D, et al
    Radiation Therapy and Chemotherapy Results in Elderly Patients With Stage III Non-Small Cell Lung Cancer: Turkish Thoracic Radiation Oncology Group Study.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  153. BAINBRIDGE HE, Menten MJ, Fast MF, Nill S, et al
    Dosimetric Implications for Radical Radiation Therapy on the Magnetic Resonance-Linear Accelerator (MRL) in Locally Advanced Non-Small Cell Lung Cancer (LA NSCLC).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  154. KOMAKI RU, Allen PK, Wei X, Welsh JW, et al
    Completing Thoracic Radiation Therapy With Concurrent Chemotherapy Within 6 weeks Is Important for Reducing Distant Disease in Patients With Limited-Stage Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  155. HANNA GG, Johnston RE, Eakin RL, Harney J, et al
    Consultant-Led Radiation Therapy Plan Peer Review Meeting and Improved Access to and Outcomes From Curative Intent Lung Cancer Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  156. SCHYTTE T, Nielsen TB, Brink C, Hansen O, et al
    Is Overall Survival in Non-Small Cell Lung Cancer Patients Treated With Definitive Radiation Therapy Affected by Dose to the Heart?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  157. APPEL S, Goldstein JD, Symon Z, Lawrence Y, et al
    Does Pathologic Response to Neoadjuvant Chemoradiation to 60 Gy Predict Survival in Locally Advanced Non-Small Cell Lung Cancer?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  158. MEN Y, Hui Z, Wang X, Liang J, et al
    The Role of Postoperative Radiation Therapy (PORT) in Combined Small Cell Lung Cancer (C-SCLC).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  159. ZHAO L, Wang S, Li-Ming X, Ren X, et al
    The Preliminary Results of Cytokine-Induced Killer Cells in Combination With Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  160. SU S, Ouyang W, Hu Y, Ma Z, et al
    Is Radiation Therapy in Addition to Chemotherapy Beneficial for Overall Survival in Patients With Nonoligometastatic Non-Small Cell Lung Cancer? Reanalysis of the Data of 2 Prospective Studies.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  161. NIELSEN TB, Nielsen M, Schytte T, Brink C, et al
    The Safety of Critical Structures Throughout Treatment for Dose-Escalated Locally Advanced Non-Small Cell Lung Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  162. ZHOU Y, Liu N, Dong Y, Huang Y, et al
    A Pilot Study of 18F-ALF-NOTA-PRGD2 PET/CT Imaging in Detecting Lymph Node Metastases in Patients With Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  163. GUO W, Gao XS, Ma MW, Han LJ, et al
    Hypofractionated Stereotactic Radiation Therapy for Advanced Non-Small Cell Lung Cancer: Report on Clinical Outcome and Toxicity.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  164. SHAFFER J, Negahdar M, von Eyben R, Diehn M, et al
    Four-Dimensional Computed Tomography Pulmonary Nodule Elastometry as a Predictor of Regional Recurrence Following Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  165. SHI A, You J, Wu Y, Yu H, et al
    A Dose Escalation Study With Intensity Modulated Radiation Therapy Using Simultaneous Integrated Boost for Limited-Disease Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  166. WONG AT, Schwartz D, Rineer JM, Safdieh J, et al
    The Impact of Thoracic Radiation Therapy Timing and Fractionation on Survival in Nonmetastatic Small Cell Lung Carcinoma Using the National Cancer Data Base.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


    September 2016
  167. VERMA V, McMillan MT, Grover S, Simone CB 2nd, et al
    Stereotactic Body Radiation Therapy and the Influence of Chemotherapy on Overall Survival for Large (>/=5 Centimeter) Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016 Sep 29. pii: S0360-3016(16)33247.
    PubMed     Text format     Abstract available


    August 2016
  168. HEPEL JT, Leonard KL, Safran H, Ng T, et al
    Stereotactic Body Radiation Therapy Boost After Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Dose Escalation Study.
    Int J Radiat Oncol Biol Phys. 2016 Aug 31. pii: S0360-3016(16)33147.
    PubMed     Text format     Abstract available


  169. BI N, Shedden K, Zheng X, Kong FM, et al
    Comparison of the Effectiveness of Radiofrequency Ablation With Stereotactic Body Radiation Therapy in Inoperable Stage I Non-Small Cell Lung Cancer: A Systemic Review and Pooled Analysis.
    Int J Radiat Oncol Biol Phys. 2016;95:1378-90.
    PubMed     Text format     Abstract available


    July 2016
  170. VINOGRADSKIY Y, Schubert L, Diot Q, Waxweiller T, et al
    Regional Lung Function Profiles of Stage I and III Lung Cancer Patients: An Evaluation for Functional Avoidance Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;95:1273-80.
    PubMed     Text format     Abstract available


    June 2016
  171. ROSSI MM, Peulen HM, Belderbos JS, Sonke JJ, et al
    Intrafraction Motion in Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer: Intensity Modulated Radiation Therapy Versus Volumetric Modulated Arc Therapy.
    Int J Radiat Oncol Biol Phys. 2016;95:835-43.
    PubMed     Text format     Abstract available


    May 2016
  172. VEIGA C, Janssens G, Teng CL, Baudier T, et al
    First Clinical Investigation of Cone Beam Computed Tomography and Deformable Registration for Adaptive Proton Therapy for Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;95:549-59.
    PubMed     Text format     Abstract available


  173. CHANG JY, Jabbour SK, De Ruysscher D, Schild SE, et al
    Consensus Statement on Proton Therapy in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;95:505-16.
    PubMed     Text format     Abstract available


  174. DUECK J, Knopf AC, Lomax A, Albertini F, et al
    Robustness of the Voluntary Breath-Hold Approach for the Treatment of Peripheral Lung Tumors Using Hypofractionated Pencil Beam Scanning Proton Therapy.
    Int J Radiat Oncol Biol Phys. 2016;95:534-41.
    PubMed     Text format     Abstract available


  175. GAMEIRO SR, Malamas AS, Bernstein MB, Tsang KY, et al
    Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell-Mediated Killing.
    Int J Radiat Oncol Biol Phys. 2016;95:120-30.
    PubMed     Text format     Abstract available


  176. MORI S, Karube M, Shirai T, Tajiri M, et al
    Carbon-Ion Pencil Beam Scanning Treatment With Gated Markerless Tumor Tracking: An Analysis of Positional Accuracy.
    Int J Radiat Oncol Biol Phys. 2016;95:258-66.
    PubMed     Text format     Abstract available


    April 2016
  177. PEULEN H, Mantel F, Guckenberger M, Belderbos J, et al
    Validation of High-Risk Computed Tomography Features for Detection of Local Recurrence After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016 Apr 12. pii: S0360-3016(16)30106.
    PubMed     Text format     Abstract available


  178. MILISAVLJEVIC S, Spasic M
    In Regard to Nagata et al.
    Int J Radiat Oncol Biol Phys. 2016;94:1219-20.
    PubMed     Text format    


    March 2016
  179. LANDAU DB, Hughes L, Baker A, Bates AT, et al
    IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016 Mar 28. pii: S0360-3016(16)00343.
    PubMed     Text format     Abstract available


  180. WU J, Gensheimer MF, Dong X, Rubin DL, et al
    Robust Intratumor Partitioning to Identify High-Risk Subregions in Lung Cancer: A Pilot Study.
    Int J Radiat Oncol Biol Phys. 2016 Mar 24. pii: S0360-3016(16)00330.
    PubMed     Text format     Abstract available


  181. KLEMENT RJ, Allgauer M, Andratschke N, Blanck O, et al
    Bayesian Cure Rate Modeling of Local Tumor Control: Evaluation in Stereotactic Body Radiation Therapy for Pulmonary Metastases.
    Int J Radiat Oncol Biol Phys. 2016;94:841-9.
    PubMed     Text format     Abstract available


  182. BINKLEY MS, Hiniker SM, Chaudhuri A, Maxim PG, et al
    Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.
    Int J Radiat Oncol Biol Phys. 2016;94:808-15.
    PubMed     Text format     Abstract available


  183. LEE HW, Noh OK, Oh YT, Choi JH, et al
    Radiation Therapy-First Strategy After Surgery With or Without Adjuvant Chemotherapy in Stage IIIA-N2 Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;94:621-7.
    PubMed     Text format     Abstract available


  184. WARNER A, Dahele M, Hu B, Palma DA, et al
    Factors Associated With Early Mortality in Patients Treated With Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;94:612-20.
    PubMed     Text format     Abstract available


  185. LEE D, Greer PB, Ludbrook J, Arm J, et al
    Audiovisual Biofeedback Improves Cine-Magnetic Resonance Imaging Measured Lung Tumor Motion Consistency.
    Int J Radiat Oncol Biol Phys. 2016;94:628-36.
    PubMed     Text format     Abstract available


  186. BODA-HEGGEMANN J, Knopf AC, Simeonova-Chergou A, Wertz H, et al
    Deep Inspiration Breath Hold-Based Radiation Therapy: A Clinical Review.
    Int J Radiat Oncol Biol Phys. 2016;94:478-92.
    PubMed     Text format     Abstract available


    February 2016
  187. SONG C, Hong BJ, Bok S, Lee CJ, et al
    Real-time Tumor Oxygenation Changes After Single High-dose Radiation Therapy in Orthotopic and Subcutaneous Lung Cancer in Mice: Clinical Implication for Stereotactic Ablative Radiation Therapy Schedule Optimization.
    Int J Radiat Oncol Biol Phys. 2016 Feb 13. pii: S0360-3016(16)00138.
    PubMed     Text format     Abstract available


  188. MAGNUSON WJ, Yeung JT, Guillod PD, Gettinger SN, et al
    Impact of Deferring Radiation Therapy in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Develop Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2016 Feb 2. pii: S0360-3016(16)00058.
    PubMed     Text format     Abstract available


  189. FRIED DV, Mawlawi O, Zhang L, Fave X, et al
    Potential Use of (18)F-fluorodeoxyglucose Positron Emission Tomography-Based Quantitative Imaging Features for Guiding Dose Escalation in Stage III Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;94:368-76.
    PubMed     Text format     Abstract available


  190. VALLE LF, Jagsi R, Bobiak SN, Zornosa C, et al
    Variation in Definitive Therapy for Localized Non-Small Cell Lung Cancer Among National Comprehensive Cancer Network Institutions.
    Int J Radiat Oncol Biol Phys. 2016;94:360-7.
    PubMed     Text format     Abstract available


  191. FITZGERALD TJ, Bishop-Jodoin M, Followill DS, Galvin J, et al
    Imaging and Data Acquisition in Clinical Trials for Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;94:404-11.
    PubMed     Text format     Abstract available


  192. NIEDZIELSKI JS, Yang J, Stingo F, Martel MK, et al
    Objectively Quantifying Radiation Esophagitis With Novel Computed Tomography-Based Metrics.
    Int J Radiat Oncol Biol Phys. 2016;94:385-93.
    PubMed     Text format     Abstract available


  193. BRIERE TM, Krafft S, Liao Z, Martel MK, et al
    Lung Size and the Risk of Radiation Pneumonitis.
    Int J Radiat Oncol Biol Phys. 2016;94:377-84.
    PubMed     Text format     Abstract available


    January 2016
  194. JIANG Y, Verbiest T, Devery AM, Bokobza SM, et al
    Hypoxia Potentiates the Radiation-Sensitizing Effect of Olaparib in Human Non-Small Cell Lung Cancer Xenografts by Contextual Synthetic Lethality.
    Int J Radiat Oncol Biol Phys. 2016 Jan 23. pii: S0360-3016(16)00056.
    PubMed     Text format     Abstract available


  195. HORINOUCHI H, Goto Y, Kanda S, Fujiwara Y, et al
    Candidates for Intensive Local Treatment in cIIIA-N2 Non-Small Cell Lung Cancer: Deciphering the Heterogeneity.
    Int J Radiat Oncol Biol Phys. 2016;94:155-62.
    PubMed     Text format     Abstract available


  196. DEEK MP, Benenati B, Kim S, Chen T, et al
    Thoracic Vertebral Body Irradiation Contributes to Acute Hematologic Toxicity During Chemoradiation Therapy for Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;94:147-54.
    PubMed     Text format     Abstract available


  197. TAKAO S, Miyamoto N, Matsuura T, Onimaru R, et al
    Intrafractional Baseline Shift or Drift of Lung Tumor Motion During Gated Radiation Therapy With a Real-Time Tumor-Tracking System.
    Int J Radiat Oncol Biol Phys. 2016;94:172-80.
    PubMed     Text format     Abstract available


  198. MACKILLOP WJ, Kong W
    Estimating the Need for Palliative Radiation Therapy: A Benchmarking Approach.
    Int J Radiat Oncol Biol Phys. 2016;94:51-9.
    PubMed     Text format     Abstract available


    December 2015
  199. MATTONEN SA, Palma DA, Johnson C, Louie AV, et al
    Detection of Local Cancer Recurrence After Stereotactic Ablative Radiation Therapy for Lung Cancer: Physician Performance Versus Radiomic Assessment.
    Int J Radiat Oncol Biol Phys. 2015 Dec 29. pii: S0360-3016(15)27223.
    PubMed     Text format     Abstract available


  200. KELSEY CR, Das S, Gu L, Dunphy FR 3rd, et al
    Phase 1 Dose Escalation Study of Accelerated Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2015;93:997-1004.
    PubMed     Text format     Abstract available


  201. NAGATA Y, Hiraoka M, Shibata T, Onishi H, et al
    Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403.
    Int J Radiat Oncol Biol Phys. 2015;93:989-996.
    PubMed     Text format     Abstract available


  202. KANG J, Schwartz R, Flickinger J, Beriwal S, et al
    Machine Learning Approaches for Predicting Radiation Therapy Outcomes: A Clinician's Perspective.
    Int J Radiat Oncol Biol Phys. 2015;93:1127-35.
    PubMed     Text format     Abstract available


    November 2015
  203. KARUBE M, Yamamoto N, Nakajima M, Yamashita H, et al
    Single-Fraction Carbon-Ion Radiation Therapy for Patients 80 Years of Age and Older With Stage I Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2015 Nov 30. pii: S0360-3016(15)26772.
    PubMed     Text format     Abstract available


  204. KIMURA T, Doi Y, Nakashima T, Imano N, et al
    Combined Ventilation and Perfusion Imaging Correlates With the Dosimetric Parameters of Radiation Pneumonitis in Radiation Therapy Planning for Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2015;93:778-87.
    PubMed     Text format     Abstract available


  205. SU S, Li T, Lu B, Wang X, et al
    Three-Dimensional Radiation Therapy to the Primary Tumor With Concurrent Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer: Results of a Multicenter Phase 2 Study From PPRA-RTOG, China.
    Int J Radiat Oncol Biol Phys. 2015;93:769-77.
    PubMed     Text format     Abstract available


  206. GUCKENBERGER M
    Dose and Fractionation in Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: Lessons Learned and Where Do We Go Next?
    Int J Radiat Oncol Biol Phys. 2015;93:765-8.
    PubMed     Text format    


  207. VIDETIC GM, Hu C, Singh AK, Chang JY, et al
    A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927).
    Int J Radiat Oncol Biol Phys. 2015;93:757-64.
    PubMed     Text format     Abstract available


  208. DOU TH, Thomas DH, O'Connell DP, Lamb JM, et al
    A Method for Assessing Ground-Truth Accuracy of the 5DCT Technique.
    Int J Radiat Oncol Biol Phys. 2015;93:925-33.
    PubMed     Text format     Abstract available


  209. YAMOAH K, Showalter TN, Ohri N
    Radiation Therapy Intensification for Solid Tumors: A Systematic Review of Randomized Trials.
    Int J Radiat Oncol Biol Phys. 2015;93:737-45.
    PubMed     Text format     Abstract available


  210. LIU W, Schild SE, Chang JY, Liao Z, et al
    Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2015 Nov 10. pii: S0360-3016(15)26684.
    PubMed     Text format     Abstract available


  211. HOPPE BS, Henderson R, Pham D, Cury JD, et al
    A Phase 2 Trial of Concurrent Chemotherapy and Proton Therapy for Stage III Non-Small Cell Lung Cancer: Results and Reflections Following Early Closure of a Single-Institution Study.
    Int J Radiat Oncol Biol Phys. 2015 Nov 10. pii: S0360-3016(15)26686.
    PubMed     Text format     Abstract available


  212. MARKOVINA S, Duan F, Snyder BS, Siegel BA, et al
    Regional Lymph Node Uptake of [(18)F]Fluorodeoxyglucose After Definitive Chemoradiation Therapy Predicts Local-Regional Failure of Locally Advanced Non-Small Cell Lung Cancer: Results of ACRIN 6668/RTOG 0235.
    Int J Radiat Oncol Biol Phys. 2015;93:597-605.
    PubMed     Text format     Abstract available


  213. TIMMERMAN RD
    The Quality of Toxicity Reporting and the Story of the Lung SBRT "No-Fly Zone". In Regard to Oskan.
    Int J Radiat Oncol Biol Phys. 2015;93:726-7.
    PubMed     Text format    


  214. LI H, Zhu XR, Zhang X
    Reducing Dose Uncertainty for Spot-Scanning Proton Beam Therapy of Moving Tumors by Optimizing the Spot Delivery Sequence.
    Int J Radiat Oncol Biol Phys. 2015;93:547-56.
    PubMed     Text format     Abstract available


  215. MINATEL E, Trovo M, Bearz A, Di Maso M, et al
    Radical Radiation Therapy After Lung-Sparing Surgery for Malignant Pleural Mesothelioma: Survival, Pattern of Failure, and Prognostic Factors.
    Int J Radiat Oncol Biol Phys. 2015;93:606-13.
    PubMed     Text format     Abstract available


  216. WESTHOFF PG, de Graeff A, Monninkhof EM, Pomp J, et al
    Quality of Life in Relation to Pain Response to Radiation Therapy for Painful Bone Metastases.
    Int J Radiat Oncol Biol Phys. 2015;93:694-701.
    PubMed     Text format     Abstract available


  217. LIU E, Santibanez P, Puterman ML, Weber L, et al
    A Quantitative Analysis of the Relationship Between Radiation Therapy Use and Travel Time.
    Int J Radiat Oncol Biol Phys. 2015;93:710-8.
    PubMed     Text format     Abstract available


    October 2015
  218. PALMA DA, Videtic GM
    Oligometastatic Non-Small-Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2015;93:223-6.
    PubMed     Text format    


  219. SIVA S, Hardcastle N, Kron T, Bressel M, et al
    Ventilation/Perfusion Positron Emission Tomography--Based Assessment of Radiation Injury to Lung.
    Int J Radiat Oncol Biol Phys. 2015;93:408-17.
    PubMed     Text format     Abstract available


  220. GOLDSTEIN JD, Lawrence YR, Appel S, Landau E, et al
    Continuous Positive Airway Pressure for Motion Management in Stereotactic Body Radiation Therapy to the Lung: A Controlled Pilot Study.
    Int J Radiat Oncol Biol Phys. 2015;93:391-9.
    PubMed     Text format     Abstract available


  221. DIN SU, Williams EL, Jackson A, Rosenzweig KE, et al
    Impact of Fractionation and Dose in a Multivariate Model for Radiation-Induced Chest Wall Pain.
    Int J Radiat Oncol Biol Phys. 2015;93:418-24.
    PubMed     Text format     Abstract available


  222. ALAM A, Mukhopadhyay ND, Ning Y, Reshko LB, et al
    A Preliminary Study on Racial Differences in HMOX1, NFE2L2, and TGFbeta1 Gene Polymorphisms and Radiation-Induced Late Normal Tissue Toxicity.
    Int J Radiat Oncol Biol Phys. 2015;93:436-43.
    PubMed     Text format     Abstract available


    September 2015
  223. WESTOVER KD, Loo BW Jr, Gerber DE, Iyengar P, et al
    Precision Hypofractionated Radiation Therapy in Poor Performing Patients With Non-Small Cell Lung Cancer: Phase 1 Dose Escalation Trial.
    Int J Radiat Oncol Biol Phys. 2015;93:72-81.
    PubMed     Text format     Abstract available


  224. MCGARRY RC
    Extensive-Stage Small Cell Lung Cancer: Is Consolidative Thoracic Radiation Therapy Really a New Standard of Care?
    Int J Radiat Oncol Biol Phys. 2015;93:10-2.
    PubMed     Text format    


  225. JEREMIC B
    Thoracic Radiation Therapy in Extensive Disease Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2015;93:7-9.
    PubMed     Text format    


  226. VERMA V, Zhen W
    Treatment Costs of Early-Stage Lung Cancers Detected by Low-Dose Computed Tomography Screening.
    Int J Radiat Oncol Biol Phys. 2015;93:207-8.
    PubMed     Text format    


  227. KAGAN AR, Schulz RJ
    Treatment Modalities Should Be Based Upon Efficacy and Cost: Early Stage NSCLC, a Case in Point.
    Int J Radiat Oncol Biol Phys. 2015;93:205-6.
    PubMed     Text format    


  228. HARDCASTLE N, Hofman MS, Hicks RJ, Callahan J, et al
    Accuracy and Utility of Deformable Image Registration in (68)Ga 4D PET/CT Assessment of Pulmonary Perfusion Changes During and After Lung Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2015;93:196-204.
    PubMed     Text format     Abstract available


  229. NG SP, David S, Alamgeer M, Ganju V, et al
    Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2015;93:111-7.
    PubMed     Text format     Abstract available


    August 2015
  230. CAMPBELL BA, Callahan J, Bressel M, Simoens N, et al
    Distribution Atlas of Proliferating Bone Marrow in Non-Small Cell Lung Cancer Patients Measured by FLT-PET/CT Imaging, With Potential Applicability in Radiation Therapy Planning.
    Int J Radiat Oncol Biol Phys. 2015;92:1035-43.
    PubMed     Text format     Abstract available


  231. XIANG L, Zhang JW, Lin S, Luo HQ, et al
    Computed Tomography-Guided Interstitial High-Dose-Rate Brachytherapy in Combination With Regional Positive Lymph Node Intensity-Modulated Radiation Therapy in Locally Advanced Peripheral Non-Small Cell Lung Cancer: A Phase 1 Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2015;92:1027-34.
    PubMed     Text format     Abstract available


  232. JAHN F, Riesner A, Jahn P, Sieker F, et al
    Addition of the Neurokinin-1-Receptor Antagonist (RA) Aprepitant to a 5-Hydroxytryptamine-RA and Dexamethasone in the Prophylaxis of Nausea and Vomiting Due to Radiation Therapy With Concomitant Cisplatin.
    Int J Radiat Oncol Biol Phys. 2015;92:1101-7.
    PubMed     Text format     Abstract available


  233. SCHUEMANN J, Giantsoudi D, Grassberger C, Moteabbed M, et al
    Assessing the Clinical Impact of Approximations in Analytical Dose Calculations for Proton Therapy.
    Int J Radiat Oncol Biol Phys. 2015;92:1157-64.
    PubMed     Text format     Abstract available


  234. BINKLEY MS, Trakul N, Jacobs LR, von Eyben R, et al
    Colorectal Histology Is Associated With an Increased Risk of Local Failure in Lung Metastases Treated With Stereotactic Ablative Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2015;92:1044-52.
    PubMed     Text format     Abstract available


    July 2015
  235. KOSHY M, Sher DJ
    In Reply to Levy et al.
    Int J Radiat Oncol Biol Phys. 2015;92:946-7.
    PubMed     Text format    


  236. LEVY A, Guckenberger M, Hurkmans C, Nestle U, et al
    SBRT Dose and Survival in Non-Small Cell Lung Cancer: In Regard to Koshy et al.
    Int J Radiat Oncol Biol Phys. 2015;92:945-6.
    PubMed     Text format    


  237. ANKER CJ, Wo JY
    Personalized Medicine in Radiation Oncology--A Work in Progress.
    Int J Radiat Oncol Biol Phys. 2015;92:843-5.
    PubMed     Text format    


  238. AL-HALABI H, Paetzold P, Sharp GC, Olsen C, et al
    A Contralateral Esophagus-Sparing Technique to Limit Severe Esophagitis Associated With Concurrent High-Dose Radiation and Chemotherapy in Patients With Thoracic Malignancies.
    Int J Radiat Oncol Biol Phys. 2015;92:803-10.
    PubMed     Text format     Abstract available


  239. JUNG J, Song SY, Yoon SM, Kwak J, et al
    Verification of Accuracy of CyberKnife Tumor-tracking Radiation Therapy Using Patient-specific Lung Phantoms.
    Int J Radiat Oncol Biol Phys. 2015;92:745-53.
    PubMed     Text format     Abstract available


  240. AHMED KA, Fulp WJ, Berglund AE, Hoffe SE, et al
    Differences Between Colon Cancer Primaries and Metastases Using a Molecular Assay for Tumor Radiation Sensitivity Suggest Implications for Potential Oligometastatic SBRT Patient Selection.
    Int J Radiat Oncol Biol Phys. 2015;92:837-42.
    PubMed     Text format     Abstract available


  241. JABBOUR SK, Kim S, Haider SA, Xu X, et al
    Reduction in Tumor Volume by Cone Beam Computed Tomography Predicts Overall Survival in Non-Small Cell Lung Cancer Treated With Chemoradiation Therapy.
    Int J Radiat Oncol Biol Phys. 2015;92:627-33.
    PubMed     Text format     Abstract available


  242. KISHI T, Matsuo Y, Ueki N, Iizuka Y, et al
    Pretreatment Modified Glasgow Prognostic Score Predicts Clinical Outcomes After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2015;92:619-26.
    PubMed     Text format     Abstract available


  243. RODRIGUES G, Senan S, Palma D
    In Reply to Cobben and Jager.
    Int J Radiat Oncol Biol Phys. 2015;92:700-1.
    PubMed     Text format    


  244. COBBEN DC, Jager PL
    In Regard to Rodrigues et al.
    Int J Radiat Oncol Biol Phys. 2015;92:699-700.
    PubMed     Text format    


  245. OSKAN F
    The Quality of Toxicity Reporting and the Story of the Lung SBRT "No-Fly Zone".
    Int J Radiat Oncol Biol Phys. 2015;92:514-5.
    PubMed     Text format    


  246. KING MT, Maxim PG, Diehn M, Loo BW Jr, et al
    Analysis of Long-Term 4-Dimensional Computed Tomography Regional Ventilation After Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2015;92:683-90.
    PubMed     Text format     Abstract available


    June 2015
  247. KOMAKI R, Allen PK, Wei X, Blumenschein GR, et al
    Adding Erlotinib to Chemoradiation Improves Overall Survival but Not Progression-Free Survival in Stage III Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2015;92:317-24.
    PubMed     Text format     Abstract available


  248. BRENNAN D, Schubert L, Diot Q, Castillo R, et al
    Clinical validation of 4-dimensional computed tomography ventilation with pulmonary function test data.
    Int J Radiat Oncol Biol Phys. 2015;92:423-9.
    PubMed     Text format     Abstract available


  249. KIRKLAND RS, Nanda RH, Alazraki A, Esiashvili N, et al
    Influence of Pulmonary Nodules on Chest Computed Tomography and Risk of Recurrence in Stage IV Wilms Tumor.
    Int J Radiat Oncol Biol Phys. 2015;92:332-8.
    PubMed     Text format     Abstract available


  250. SON CH, Bae JH, Shin DY, Lee HR, et al
    Combination effect of regulatory T-cell depletion and ionizing radiation in mouse models of lung and colon cancer.
    Int J Radiat Oncol Biol Phys. 2015;92:390-8.
    PubMed     Text format     Abstract available


    May 2015
  251. LOUIE AV, Haasbeek CJ, Mokhles S, Rodrigues GB, et al
    Predicting Overall Survival After Stereotactic Ablative Radiation Therapy in Early-Stage Lung Cancer: Development and External Validation of the Amsterdam Prognostic Model.
    Int J Radiat Oncol Biol Phys. 2015 May 9. pii: S0360-3016(15)00503.
    PubMed     Text format     Abstract available


  252. FILIPPI AR, Ragona R, Piva C, Scafa D, et al
    Optimized Volumetric Modulated Arc Therapy Versus 3D-CRT for Early Stage Mediastinal Hodgkin Lymphoma Without Axillary Involvement: A Comparison of Second Cancers and Heart Disease Risk.
    Int J Radiat Oncol Biol Phys. 2015;92:161-8.
    PubMed     Text format     Abstract available


  253. YAHALOM J, Illidge T, Specht L, Hoppe RT, et al
    Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group.
    Int J Radiat Oncol Biol Phys. 2015;92:11-31.
    PubMed     Text format     Abstract available


    April 2015
  254. LUCAS JT JR, Colmer HG 4th, White L, Fitzgerald N, et al
    Competing Risk Analysis of Neurologic versus Nonneurologic Death in Patients Undergoing Radiosurgical Salvage After Whole-Brain Radiation Therapy Failure: Who Actually Dies of Their Brain Metastases?
    Int J Radiat Oncol Biol Phys. 2015 Apr 23. pii: S0360-3016(15)00432.
    PubMed     Text format     Abstract available


  255. CHO BC
    In reply to Cihoric and Jeremic.
    Int J Radiat Oncol Biol Phys. 2015;91:1112-3.
    PubMed     Text format    


  256. CIHORIC N, Jeremic B
    Elective nodal irradiation in early non-small cell lung cancer. In regard to Lao et al.
    Int J Radiat Oncol Biol Phys. 2015;91:1111-2.
    PubMed     Text format    


  257. HAMILTON SN, Tyldesley S, Li D, Olson R, et al
    Second Malignancies After Adjuvant Radiation Therapy for Early Stage Breast Cancer: Is There Increased Risk With Addition of Regional Radiation to Local Radiation?
    Int J Radiat Oncol Biol Phys. 2015;91:977-985.
    PubMed     Text format     Abstract available


    March 2015
  258. CHEN AB
    In reply to Lo et al.
    Int J Radiat Oncol Biol Phys. 2015;91:880-1.
    PubMed     Text format    


  259. AZNAR MC, Maraldo MV, Schut DA, Lundemann M, et al
    Minimizing Late Effects for Patients With Mediastinal Hodgkin Lymphoma: Deep Inspiration Breath-Hold, IMRT, or Both?
    Int J Radiat Oncol Biol Phys. 2015 Mar 5. pii: S0360-3016(15)00054.
    PubMed     Text format     Abstract available


    January 2015
  260. BRINK C, Bernchou U, Bertelsen A, Hansen O, et al
    In reply to Yamazaki et al.
    Int J Radiat Oncol Biol Phys. 2015;91:245-6.
    PubMed     Text format    


  261. YAMAZAKI H, Nakamura S, Aibe N, Nishimura T, et al
    In regard to Brink et al.
    Int J Radiat Oncol Biol Phys. 2015;91:244-5.
    PubMed     Text format    


  262. SPERDUTO PW, Song CW, Kirkpatrick JP, Glatstein E, et al
    A hypothesis: indirect cell death in the radiosurgery era.
    Int J Radiat Oncol Biol Phys. 2015;91:11-3.
    PubMed     Text format    


  263. OHRI N, Rapkin BD, Guha D, Haynes-Lewis H, et al
    Predictors of radiation therapy noncompliance in an urban academic cancer center.
    Int J Radiat Oncol Biol Phys. 2015;91:232-8.
    PubMed     Text format     Abstract available


  264. LI HH, Rodriguez VL, Green OL, Hu Y, et al
    Patient-specific quality assurance for the delivery of (60)Co intensity modulated radiation therapy subject to a 0.35-T lateral magnetic field.
    Int J Radiat Oncol Biol Phys. 2015;91:65-72.
    PubMed     Text format     Abstract available


  265. MANGONA VS, Aneese AM, Marina O, Hymas RV, et al
    Toxicity after central versus peripheral lung stereotactic body radiation therapy: a propensity score matched-pair analysis.
    Int J Radiat Oncol Biol Phys. 2015;91:124-32.
    PubMed     Text format     Abstract available


  266. CHANCE WW, Rice DC, Allen PK, Tsao AS, et al
    Hemithoracic intensity modulated radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and a matched survival analysis.
    Int J Radiat Oncol Biol Phys. 2015;91:149-56.
    PubMed     Text format     Abstract available


    October 2014
  267. KIRKPATRICK JP, Wang Z, Sampson JH, McSherry F, et al
    Defining the Optimal Planning Target Volume in Image-Guided Stereotactic Radiosurgery of Brain Metastases: Results of a Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2014 Oct 21. pii: S0360-3016(14)04088.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: